Conserved respiratory virus surface features

Conserved respiratory virus surface features refer to highly stable structural motifs on the surface glycoproteins of respiratory viruses, such as the hemagglutinin (HA) stem in influenza, the S2 subunit of the coronavirus spike protein, and the fusion (F) protein of respiratory syncytial virus (RSV) (NIH, Nature Reviews Microbiology). These features are essential for the viral life cycle, particularly in mediating the fusion of the viral envelope with the host cell membrane, a process critical for viral entry (Science). Because these regions are functionally constrained, they exhibit significantly lower mutation rates compared to other surface areas, making them ideal targets for broadly neutralizing antibodies (bnAbs) and universal vaccine development (Nature). Therapeutic agents like Sotrovimab and Nirsevimab target these conserved epitopes to provide broad-spectrum protection against multiple viral variants (GSK/Vir, AstraZeneca). By binding to these sites, drugs can neutralize the virus by blocking conformational changes required for entry or by recruiting host immune cells through Fc-mediated effector functions (PubMed). Targeting these conserved features represents a strategic shift toward pan-viral therapies capable of addressing both seasonal outbreaks and emerging pandemic threats (NIH).

Other names

Conserved viral epitopesBroadly neutralizing antibody targetsUniversal vaccine epitopesConserved surface glycoproteinsPan-viral targetsConserved viral surface motifs

Neutralization of viral entry through binding to conserved epitopes on surface glycoproteins, thereby inhibiting membrane fusion or host cell attachment.